DS
MRNA icon

DRW Securities’s Moderna MRNA Stock Holding History

DRW Securities’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,442
Closed -$249K – 1582
2025
Q4 		$249K Buy
+8,442
New +$229K 0.01% 791
2024
Q2 		– Sell
-2,404
Closed -$256K – 591
2024
Q1 		$256K Buy
+2,404
New +$242K 0.01% 302
2022
Q2 		– Sell
-1,455
Closed -$251K – 311
2022
Q1 		$251K Buy
1,455
+370
+34% +$62.3K 0.01% 231
2021
Q4 		$276K Buy
+1,085
New +$317K 0.01% 192
2021
Q1 		– Sell
-2,366
Closed -$247K – 211
2020
Q4 		$247K Buy
+2,366
New +$239K 0.01% 107

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DRW Securities's MRNA Position: Q1 2026 in Review

DRW Securities sold out of Moderna (MRNA) in Q1 2026, closing a stake of 8,442 shares — an estimated $249K sold.

DRW Securities first reported a position in MRNA in Q4 2020 and held it in 5 quarters. The position peaked at $276K in Q4 2021. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • DRW Securities reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • DRW Securities sold 8,442 Moderna shares in Q1 2026, an estimated $249K.
  • DRW Securities first reported a position in Moderna in Q4 2020 and held it in 5 quarters.
  • DRW Securities's Moderna position peaked at $276K in Q4 2021.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.